Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Nowicka

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Molecular Psychiatry|March 31, 2022
Targeted therapy of cognitive deficits in fragile X syndromeA Puścian, M Winiarski, J Borowska, et al.
Clinical and Translational Radiation Oncology|August 27, 2024
Acute toxicities in proton therapy for head and neck cancer - A matched analysis of the DAHANCA 35 feasibility studyK Nowicka-Matus, J Friborg, C R Hansen, et al.
Structure (London, England : 1993)|November 21, 2017
Structural Basis for the Inhibitory Effects of Ubistatins in the Ubiquitin-Proteasome PathwayMark A Nakasone, Timothy A Lewis, Olivier Walker, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Molecular Psychiatry|March 31, 2022
Targeted therapy of cognitive deficits in fragile X syndromeA Puścian, M Winiarski, J Borowska, et al.
Clinical and Translational Radiation Oncology|August 27, 2024
Acute toxicities in proton therapy for head and neck cancer - A matched analysis of the DAHANCA 35 feasibility studyK Nowicka-Matus, J Friborg, C R Hansen, et al.
Structure (London, England : 1993)|November 21, 2017
Structural Basis for the Inhibitory Effects of Ubistatins in the Ubiquitin-Proteasome PathwayMark A Nakasone, Timothy A Lewis, Olivier Walker, et al.
Pageof 4